Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acid esters
Reexamination Certificate
2011-03-22
2011-03-22
Witherspoon, Sikarl A (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acid esters
C514S255010
Reexamination Certificate
active
07910767
ABSTRACT:
Prostaglandin nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.
REFERENCES:
patent: 3922293 (1975-11-01), Morozowich
patent: 4952581 (1990-08-01), Bito
patent: 5625083 (1997-04-01), Bezuglov
patent: 5811443 (1998-09-01), DeSantis, Jr.
patent: 6211233 (2001-04-01), Del Soldato
patent: 6242432 (2001-06-01), Del Soldato
patent: 6417228 (2002-07-01), Klimko
patent: 7273946 (2007-09-01), Ongini et al.
patent: 7449469 (2008-11-01), Ongini et al.
patent: 7629345 (2009-12-01), Ongini et al.
patent: WO 90/02553 (1990-03-01), None
patent: WO 94/10141 (1994-05-01), None
patent: WO 98/58910 (1998-12-01), None
patent: WO 00/51978 (2000-09-01), None
patent: WO 2005/068421 (2005-07-01), None
Alm, A., “Prostaglandin Derivatives As Ocular Hypotensive Agents,”Progress In Retinal And Eye Research, 1997, 291-312, vol. 17, No. 3.
Arnaud, C.H., “Drug Hybrids Enter the Fray,”Chemical&Engineering News, 2007, 46-48, vol. 85, No. 46.
Beers, M.H., et al., The Merck Manual of Diagnosis and Therapy, Section 8, Chapter 100.
Greene, T.W., “Protective Groups in Organic Synthesis,” Harvard University Press, 1980, 14-118.
Greene, T.W., “Protective Groups in Organic Synthesis,” Harvard University Press, 1980, 68-86.
Benedini Francesca
Chiroli Valerio
Del Soldato Piero
Ongini Ennio
Arent & Fox LLP
Nicox S.A.
Witherspoon Sikarl A
LandOfFree
Prostaglandin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostaglandin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostaglandin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2684487